Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VALN · against 422 other Healthcare companies of similar size
Ranked #340 of 423 · scores higher than 18% of peers
Bars: peers in each 10-point band of the growth score71 peers with a growth score of 10–19, including VALN · Click a bar to see the companies
Mainly because of its 3-year revenue growth, earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | VALN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 436 reported | 3.0% | 2.8% | 51% | 33% | |
| Earnings per share growthHigher is better · 218 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 413 reported | -21.5% | 2.9% | 7% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 340 | 4.4B CNY (≈$612M) | 13 | 33 | |
| 340 | 3.7B CNY (≈$520M) | 13 | 50 | |
| 340 | 7.2B CNY (≈$1.0B) | 13 | 34 | |
| 340 | 549M USD | 13 | 30 | |
| 340 | 522M USD | 13 | 12 | |
| 349 | 7.2B CNY (≈$1.0B) | 12 | 69 | |
| 349 | 5.3B CNY (≈$738M) | 12 | 40 | |
| 349 | 2.9B CNY (≈$411M) | 12 | 23 | |
| 349 | 7.2B CNY (≈$1.0B) | 12 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score